Rosa Coll

868 total citations
20 papers, 181 citations indexed

About

Rosa Coll is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Rosa Coll has authored 20 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 6 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Rosa Coll's work include Acute Myeloid Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Epigenetics and DNA Methylation (4 papers). Rosa Coll is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Epigenetics and DNA Methylation (4 papers). Rosa Coll collaborates with scholars based in Spain, United States and United Kingdom. Rosa Coll's co-authors include Megan Greally, Thomas D. Cooney, Lurdes Zamora, David Gallardo, Montserrat Arnán, Susana Vives, Mar Tormo, Olga Salamero, Ana Garrido and Joan Bargay and has published in prestigious journals such as Blood, British Journal of Haematology and Journal of Clinical Pathology.

In The Last Decade

Rosa Coll

17 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosa Coll Spain	9	99	82	54	28	24	20	181
Kalman Filanovsky Israel	6	125 1.3×	38 0.5×	44 0.8×	35 1.3×	17 0.7×	21	192
Fernando Roncolato Australia	8	109 1.1×	57 0.7×	48 0.9×	16 0.6×	14 0.6×	17	183
Jean‐Valère Malfuson France	8	143 1.4×	142 1.7×	42 0.8×	29 1.0×	32 1.3×	15	250
Carmen Sanzo Spain	5	166 1.7×	48 0.6×	84 1.6×	48 1.7×	31 1.3×	5	211
Amanda R. Leonti United States	8	113 1.1×	99 1.2×	36 0.7×	33 1.2×	35 1.5×	32	193
Mahesh Swaminathan United States	8	172 1.7×	111 1.4×	81 1.5×	30 1.1×	14 0.6×	31	239
Torsten Haferlach Germany	3	177 1.8×	106 1.3×	44 0.8×	77 2.8×	25 1.0×	8	235
Sivahari Prasad Gorantla Germany	7	83 0.8×	70 0.9×	54 1.0×	13 0.5×	26 1.1×	24	162
Pamela Acha Spain	5	147 1.5×	89 1.1×	92 1.7×	50 1.8×	12 0.5×	8	206
Francesca Messa Italy	7	166 1.7×	152 1.9×	67 1.2×	63 2.3×	26 1.1×	28	255

Countries citing papers authored by Rosa Coll

Since Specialization

Citations

This map shows the geographic impact of Rosa Coll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Coll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Coll more than expected).

Fields of papers citing papers by Rosa Coll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Coll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Coll. The network helps show where Rosa Coll may publish in the future.

Co-authorship network of co-authors of Rosa Coll

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Coll. A scholar is included among the top collaborators of Rosa Coll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Coll. Rosa Coll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruiz‐Xivillé, Neus, Lurdes Zamora, Susana Vives, et al.. (2024). Identification of novel NUP98 fusion partners and comutations in acute myeloid leukemia: an adult cohort study. Blood Advances. 8(11). 2691–2694. 6 indexed citations

Salamero, Olga, Josè Antonio Pérez-Simón, Montserrat Arnán, et al.. (2024). Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study. The Lancet Haematology. 11(7). e487–e498. 9 indexed citations

Pratcorona, Marta, Ana Garrido, Álex Bataller, et al.. (2023). Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort. Blood Cancer Journal. 13(1). 69–69. 9 indexed citations

Morgades, Mireia, Marta Cervera, Marina Díaz‐Beyá, et al.. (2022). P569: GILTERITINIB AND QUIZARTINIB IN RELAPSED/REFRACTORY (R/R) ACUTE MYELOBLASTIC LEUKEMIA (AML) WITH FLT3 MUTATIONS: A REAL-LIFE EFFECTIVENESS AND SAFETY STUDY. HemaSphere. 6. 468–469.

Salamero, Olga, Tim C. P. Somervaille, Josè Antonio Pérez-Simón, et al.. (2022). Iadademstat Combination with Azacitidine Is a Safe and Effective Treatment in First Line Acute Myeloid Leukemia. Final Results of the Alice Trial. Blood. 140(Supplement 1). 1711–1713. 7 indexed citations

Pratcorona, Marta, Lurdes Zamora, Mònica López‐Guerra, et al.. (2022). RAS Mutations in Adult Acute Myeloid Leukemia (AML). Frequency, Mutational Spectrum, and Identification of a Comutation Bias for KRASK117 (TET2/ASXL1). Blood. 140(Supplement 1). 11821–11823. 1 indexed citations

Bataller, Álex, Ana Garrido, Montserrat Hoyos, et al.. (2021). Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1. Blood Advances. 6(3). 882–890. 19 indexed citations

Moral, Sergio, et al.. (2021). The Diagnostic and Etiologic Challenge of Myocarditis in Oncologic Patients: Acute Myocarditis During Induction Treatment with All-Trans Retinoic Acid. American Journal of Infectious Diseases. 17(2). 101–106.

Ribera, Jordi, Isabel Granada, Mireia Morgades, et al.. (2021). Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3‐PBX1 treated with measurable residual disease‐oriented protocols. British Journal of Haematology. 196(3). 670–675. 6 indexed citations

10.

Malinverni, Roberto, Joan Bargay, Blanca Xicoy, et al.. (2021). Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival. Clinical Epigenetics. 13(1). 9–9. 23 indexed citations

11.

Pomares, Helena, Susana Vives, Rosa Coll, et al.. (2021). Venetoclax Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia. Blood. 138(Supplement 1). 4421–4421.

12.

Salamero, Olga, Tim C. P. Somervaille, Josè Antonio Pérez-Simón, et al.. (2021). Iadademstat in Combination with Azacitidine Generates Robust and Long Lasting Responses in AML Patients (ALICE Trial). Blood. 138(Supplement 1). 3376–3376. 3 indexed citations

13.

Sánchez, Ricardo, Jordi Ribera, Mireia Morgades, et al.. (2020). A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics. Blood Cancer Journal. 10(4). 43–43. 12 indexed citations

14.

Gattermann, Norbert, et al.. (2018). Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int‐1‐risk MDS patients: Results of the phase II KALLISTO trial. European Journal Of Haematology. 101(2). 208–215. 3 indexed citations

15.

Palomo, Laura, Roberto Malinverni, Blanca Xicoy, et al.. (2017). DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features. Epigenetics. 13(1). 8–18. 11 indexed citations

16.

Palomo, Laura, Blanca Xicoy, Olga García, et al.. (2015). Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases. American Journal of Hematology. 91(2). 185–192. 13 indexed citations

17.

Coll, Rosa, David Valcárcel, Mar Tormo, et al.. (2014). IMPACT of Therapeutic Strategy and Time to Therapy Initiation on Clinical Evolution in Higher-Risk Myelodysplastic Syndromes. a Report from Erasme Study. Blood. 124(21). 1908–1908. 1 indexed citations

18.

Pérez-García, Arianne, Gemma Osca‐Gelis, Rocío Rodriguez, et al.. (2013). Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription. Human Immunology. 74(9). 1219–1224. 27 indexed citations

19.

Sancho, Juan‐Manuel, Santiago Gardella, Rosa Coll, et al.. (2009). Doxorrubicina liposomal no pegilada en combinación con ciclofosfamida, vincristina, prednisona y rituximab en el tratamiento de linfomas no hodgkinianos: estudio de 26 pacientes. Medicina Clínica. 134(2). 72–75. 4 indexed citations

20.

Cooney, Thomas D., et al.. (1977). 'Pseudocirrhosis' in hereditary haemorrhagic telangiectasia.. Journal of Clinical Pathology. 30(12). 1134–1141. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact